Quality pharmaceutical cannabis for those who need it most
We collaborate with healthcare professionals, patients, and families to ensure they have access to the only reliable pharmaceutical solution for treating complex neurological conditions, such as Dravet Syndrome, Lennox- Gastaut Syndrome, and Sclerotic Tuberosis Complex, with highly positive results. Monitored by patient follow-ups since the launch date.

History
Since 2017, we have been working on the research and development of pharmaceutical products containing cannabis, at a time when pharmaceutical alternatives in international markets were nonexistent.

Our History
Equipment
With a strong commitment, we work to provide solutions for patients with drug-resistant epilepsy and other neurological conditions, ensuring appropriate and high-quality treatment.

Executive Team
Latest News